AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE WITH RALTITREXED (TOMUDEX) AND ITS COMPARISON WITH PROTRACTED VENOUS INFUSION 5-FLUOROURACIL, AND BOLUS 5-FLUOROURACIL
Authors: SCASE A ROSS P CUNNINGHAM D NORMAN A PRENDIVILLE J WEBB A OATES J
Citation: A. Scase et al., THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE WITH RALTITREXED (TOMUDEX) AND ITS COMPARISON WITH PROTRACTED VENOUS INFUSION 5-FLUOROURACIL, AND BOLUS 5-FLUOROURACIL, GI cancer (Print), 2(4), 1998, pp. 267-275
LOCALIZED DYSTROPHIC PERIOCULAR CALCIFICATION - A COMPLICATION OF INTRALESIONAL CORTICOSTEROID-THERAPY FOR INFANTILE PERIOCULAR HEMANGIOMAS
Authors: CARRUTHERS J JEVON G PRENDIVILLE J
Citation: J. Carruthers et al., LOCALIZED DYSTROPHIC PERIOCULAR CALCIFICATION - A COMPLICATION OF INTRALESIONAL CORTICOSTEROID-THERAPY FOR INFANTILE PERIOCULAR HEMANGIOMAS, Pediatric dermatology, 15(1), 1998, pp. 23-26
RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: EISEN T SMITH IE JOHNSTON S ELLIS PA PRENDIVILLE J SEYMOUR MT WALSH G ASHLEY S
Citation: T. Eisen et al., RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1350-1357
INFUSIONAL 5-FLUOROURACIL IN THE TREATMENT OF GASTROINTESTINAL CANCERS - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE
Authors: ROSS PJ WEBB A CUNNINGHAM D PRENDIVILLE J NORMAN AR OATES J
Citation: Pj. Ross et al., INFUSIONAL 5-FLUOROURACIL IN THE TREATMENT OF GASTROINTESTINAL CANCERS - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE, Annals of oncology, 8(2), 1997, pp. 111-115
A PROSPECTIVE RANDOMIZED TRIAL OF PROTRACTED VENOUS INFUSION 5-FLUOROURACIL WITH OR WITHOUT MITOMYCIN-C IN ADVANCED COLORECTAL-CANCER
Authors: ROSS P NORMAN A CUNNINGHAM D WEBB A IVESON T PADHANI A PRENDIVILLE J WATSON M MASSEY A POPESCU R OATES J
Citation: P. Ross et al., A PROSPECTIVE RANDOMIZED TRIAL OF PROTRACTED VENOUS INFUSION 5-FLUOROURACIL WITH OR WITHOUT MITOMYCIN-C IN ADVANCED COLORECTAL-CANCER, Annals of oncology, 8(10), 1997, pp. 995-1001
TOPICAL CALCIPOTRIOL IN CHILDHOOD PSORIASIS
Authors: ORANJE AP MARCOUX D SVENSSON A PRENDIVILLE J KRAFCHIK B TOOLE J ROSENTHAL D DEWAARDVANDERSPEK FB MOLIN L AXELSEN M
Citation: Ap. Oranje et al., TOPICAL CALCIPOTRIOL IN CHILDHOOD PSORIASIS, Journal of the American Academy of Dermatology, 36(2), 1997, pp. 203-208
GEMCITABINE
Authors: PRENDIVILLE J OBRIEN M
Citation: J. Prendiville et M. Obrien, GEMCITABINE, British Journal of Hospital Medicine, 57(8), 1997, pp. 405
A RANDOMIZED TRIAL INVESTIGATING THE DOSE INTENSITY OF PRIMARY CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA - A COMPARISON OF CHEMOTHERAPY GIVEN EVERY 4 WEEKS WITH THE SAME CHEMOTHERAPY GIVEN AT 3 WEEK INTERVALS
Authors: WRIGLEY E WEAVER A JAYSON G RANSON M RENNINSON J PRENDIVILLE J DOBSON M COLLINS CD SWINDELL R BUCKLEY CH RADFORD JA CROWTHER D
Citation: E. Wrigley et al., A RANDOMIZED TRIAL INVESTIGATING THE DOSE INTENSITY OF PRIMARY CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA - A COMPARISON OF CHEMOTHERAPY GIVEN EVERY 4 WEEKS WITH THE SAME CHEMOTHERAPY GIVEN AT 3 WEEK INTERVALS, Annals of oncology, 7(7), 1996, pp. 705-711
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A PARTIALLY HLA-MISMATCHED UNRELATED DONOR FOR PROGRESSIVE CHRONIC LYMPHOCYTIC-LEUKEMIA AND FLUDARABINE-INDUCED BONE-MARROW FAILURE
Authors: MEHTA J POWLES R SINGHAL S MATTHEY F HAMBLIN M MIDDLETON G PRENDIVILLE J GLYNNE P ZOMAS A TRELEAVEN J CATOVSKY D
Citation: J. Mehta et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A PARTIALLY HLA-MISMATCHED UNRELATED DONOR FOR PROGRESSIVE CHRONIC LYMPHOCYTIC-LEUKEMIA AND FLUDARABINE-INDUCED BONE-MARROW FAILURE, Bone marrow transplantation, 17(5), 1996, pp. 881-883
IDARUBICIN, HIGH-DOSE CYTARABINE, AND ETOPOSIDE FOR INDUCTION OF REMISSION IN ACUTE-LEUKEMIA
Authors: MEHTA J POWLES R SINGHAL S HORTON C HAMBLIN M ZOMAS A SASO R PRENDIVILLE J GLYNNE P ALLFORD S MACKAY H TRELEAVEN J
Citation: J. Mehta et al., IDARUBICIN, HIGH-DOSE CYTARABINE, AND ETOPOSIDE FOR INDUCTION OF REMISSION IN ACUTE-LEUKEMIA, Seminars in hematology, 33(4), 1996, pp. 18-23
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA AFTER MELPHALAN AND TOTAL-BODY IRRADIATION
Authors: MEHTA J POWLES R SINGHAL S TAIT D HJIYIANNAKIS P PRENDIVILLE J GLYNNE P HORTON C TRELEAVEN J
Citation: J. Mehta et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA AFTER MELPHALAN AND TOTAL-BODY IRRADIATION, European journal of cancer, 31A, 1995, pp. 1130-1130
IMMUNOTHERAPY FOR ACUTE-LEUKEMIA RELAPSING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SINGHAL S POWLES R TRELEAVEN J PRENDIVILLE J GLYNNE P MEHTA J
Citation: S. Singhal et al., IMMUNOTHERAPY FOR ACUTE-LEUKEMIA RELAPSING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, European journal of cancer, 31A, 1995, pp. 1134-1134
HIGH COMPLETE REMISSION RATES WITH PRIMARY NEOADJUVANT INFUSIONAL CHEMOTHERAPY FOR LARGE EARLY BREAST-CANCER
Authors: SMITH IE WALSH G JONES A PRENDIVILLE J JOHNSTON S GUSTERSON B RAMAGE F ROBERTSHAW H SACKS N EBBS S MCKINNA JA BAUM M
Citation: Ie. Smith et al., HIGH COMPLETE REMISSION RATES WITH PRIMARY NEOADJUVANT INFUSIONAL CHEMOTHERAPY FOR LARGE EARLY BREAST-CANCER, Journal of clinical oncology, 13(2), 1995, pp. 424-429
A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
Authors: JAYSON GC CROWTHER D PRENDIVILLE J MCGOWN AT SCHEID C STERN P YOUNG R BRENCHLEY P CHANG J OWENS S PETTIT GR
Citation: Gc. Jayson et al., A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION, British Journal of Cancer, 72(2), 1995, pp. 461-468
IDARUBICIN, HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR INDUCTION OF REMISSION IN ACUTE MYELOID-LEUKEMIA
Authors: SINGHAL S POWLES R TRELEAVEN J HORTON C HAMBLIN M ZOMAS A PRENDIVILLE J SASO R MACKAY H MILAN S MEHTA J
Citation: S. Singhal et al., IDARUBICIN, HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR INDUCTION OF REMISSION IN ACUTE MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 2039-2039
LONG-TERM RENAL DYSFUNCTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: GLYNNE P POWLES R STEELE J SINGHAL S PRENDIVILLE J HORTON C TRELEAVEN J MEHTA J
Citation: P. Glynne et al., LONG-TERM RENAL DYSFUNCTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3775-3775
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MEHRA J POWLES R SINGHAL S PRENDIVILLE J GLYNNE P ZOMAS A HAMBLIN M SASO R MACKAY H SWANSBURY GJ TRELEAVEN J CATOVSKY D
Citation: J. Mehra et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 3821-3821
MEMBRANOUS APLASIA CUTIS WITH HAIR COLLARS - CONGENITAL ABSENCE OF SKIN OR NEUROECTODERMAL DEFECT
Authors: DROLET B PRENDIVILLE J GOLDEN J ENJOLRAS O ESTERLY NB
Citation: B. Drolet et al., MEMBRANOUS APLASIA CUTIS WITH HAIR COLLARS - CONGENITAL ABSENCE OF SKIN OR NEUROECTODERMAL DEFECT, Archives of dermatology, 131(12), 1995, pp. 1427-1431
CARCINOSARCOMA OF THE OVARY TREATED OVER A 10-YEAR PERIOD AT THE CHRISTIE-HOSPITAL
Authors: PRENDIVILLE J MURPHY D RENNINSON J BUCKLEY H CROWTHER D
Citation: J. Prendiville et al., CARCINOSARCOMA OF THE OVARY TREATED OVER A 10-YEAR PERIOD AT THE CHRISTIE-HOSPITAL, International journal of gynecological cancer, 4(3), 1994, pp. 200-205
THERAPY FOR SMALL-CELL LUNG-CANCER USING CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE (WITHOUT DOSE REDUCTION), MID-CYCLE VINCRISTINE WITH THORACIC AND CRANIAL IRRADIATION
Authors: PRENDIVILLE J LORIGAN P HICKS F LEAHY B STOUT R BURT P THATCHER N
Citation: J. Prendiville et al., THERAPY FOR SMALL-CELL LUNG-CANCER USING CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE (WITHOUT DOSE REDUCTION), MID-CYCLE VINCRISTINE WITH THORACIC AND CRANIAL IRRADIATION, European journal of cancer, 30A(14), 1994, pp. 2085-2090
IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO
Authors: SCHEID C PRENDIVILLE J JAYSON G CROWTHER D FOX B PETTIT GR STERN PL
Citation: C. Scheid et al., IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 223-230
ESTABLISHMENT OF A MURINE LEUKEMIA-CELL LINE RESISTANT TO THE GROWTH-INHIBITORY EFFECT OF BRYOSTATIN-1
Authors: PRENDIVILLE J MCGOWN AT GESCHER A DICKSON AJ COURAGE C PETTIT GR CROWTHER D FOX BW
Citation: J. Prendiville et al., ESTABLISHMENT OF A MURINE LEUKEMIA-CELL LINE RESISTANT TO THE GROWTH-INHIBITORY EFFECT OF BRYOSTATIN-1, British Journal of Cancer, 70(4), 1994, pp. 573-578
A PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 ADMINISTERED BY THE INTRAVENOUS AND SUBCUTANEOUS ROUTE IN PATIENTS WITH ADVANCED CANCER - IMMUNOLOGICAL STUDIES
Authors: GHOSH AK SMITH NK PRENDIVILLE J THATCHER N CROWTHER D STERN PL
Citation: Ak. Ghosh et al., A PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 ADMINISTERED BY THE INTRAVENOUS AND SUBCUTANEOUS ROUTE IN PATIENTS WITH ADVANCED CANCER - IMMUNOLOGICAL STUDIES, European cytokine network, 4(3), 1993, pp. 205-211
RECOMBINANT HUMAN INTERLEUKIN-4 (RHU IL-4) ADMINISTERED BY THE INTRAVENOUS AND SUBCUTANEOUS ROUTES IN PATIENTS WITH ADVANCED CANCER - A PHASE-I TOXICITY STUDY AND PHARMACOKINETIC ANALYSIS
Authors: PRENDIVILLE J THATCHER N LIND M MCINTOSH R GHOSH A STERN P CROWTHER D
Citation: J. Prendiville et al., RECOMBINANT HUMAN INTERLEUKIN-4 (RHU IL-4) ADMINISTERED BY THE INTRAVENOUS AND SUBCUTANEOUS ROUTES IN PATIENTS WITH ADVANCED CANCER - A PHASE-I TOXICITY STUDY AND PHARMACOKINETIC ANALYSIS, European journal of cancer, 29A(12), 1993, pp. 1700-1707
A RANDOMIZED DOSE INTENSITY STUDY IN OVARIAN-CARCINOMA COMPARING CHEMOTHERAPY GIVEN AT 4 WEEK INTERVALS FOR 6 CYCLES WITH HALF DOSE CHEMOTHERAPY GIVEN FOR 12 CYCLES
Authors: MURPHY D CROWTHER D RENNINSON J PRENDIVILLE J RANSON M LIND M PATEL U DOUGAL M BUCKLEY CH TINDALL VR
Citation: D. Murphy et al., A RANDOMIZED DOSE INTENSITY STUDY IN OVARIAN-CARCINOMA COMPARING CHEMOTHERAPY GIVEN AT 4 WEEK INTERVALS FOR 6 CYCLES WITH HALF DOSE CHEMOTHERAPY GIVEN FOR 12 CYCLES, Annals of oncology, 4(5), 1993, pp. 377-383
Risultati: 1-25 | 26-28